简体
简体中文
繁體中文

Picard Medical PMI 深 沪

已收盘 10-02 16:00:00 美东时间

5.78

+1.460

+33.80%

华盛通华盛通
立即下载
  • 最 高5.90
  • 今 开4.32
  • 成交量 89.00万股
  • 最 低 3.8501
  • 昨 收 4.32
  • 总市值 1351.73万
  • 52周最高 684.00
  • 市盈率 静 --
  • 换手率 38.06%
  • 52周最低 2.652
  • 委 比 0.00%
  • 总股本 233.86万
  • 历史最高 684.00
  • 量 比 30.05
  • 振 幅 47.45%
  • 历史最低 3.8501
  • 每 手 1
  • 风险率 128.48%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Why Is Picard Medical Stock Gaining Monday?

    Picard Medical Inc. (NYSE:PMI) stock rose Monday after the artificial heart maker’s second-quarter revenue nearly doubled Wall Street expectations, helping investors look past a wider-than-expected per-share loss. Picard Medical Revenue Jumps 39% Picard Medical reported a quarterly loss of $3.05 per...

    08-24 21:49

  • Why Planet Green Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket

    Shares of Planet Green Holdings Corp (NYSE:PLAG) rose sharply in pre-market trading after Curvature Securities announced it is terminating the sales agreement with the company. Planet Green shares jumped 11.4% to $0.76 in pre-market trading. Here are some other stocks moving in pre-market trading. G...

    08-24 17:13

  • Picard Medical Q2 EPS $(3.05) Misses $(1.50) Estimate, Sales $2.954M Beat $1.550M Estimate

    Picard Medical (AMEX:PMI) reported quarterly losses of $(3.05) per share which missed the analyst consensus estimate of $(1.50) by 103.33 percent. This is a 92.8 percent increase over losses of $(42.39) per share from the same period last year. The company reported quarterly sales of $2.954 million ...

    08-20 05:35

  • Picard Medical Reports Second Quarter 2026 Financial Results

    Picard Medical reported Q2 2026 revenue up 39% to $3.0 million, with net loss down 16% to $5.7 million. The company advanced its Emperor Total Artificial Heart platform, improving manufacturing efficiency and supply-chain resilience. A 1-for-50 reverse stock split was completed to support NYSE American listing compliance.

    08-19 21:30

  • Picard Medical’s NYSE compliance plan supports growth

    The latest update is out from Picard Medical, Inc. ( ($PMI) ). On July 22, 2026...

    07-27 21:28

  • Picard Medical regains NYSE compliance

    Picard Medical (PMI) said that the NYSE American has accepted its plan to regain compliance with the exchange's continued listing standards. The company said it has been granted a compliance period th...

    07-27 19:32

  • Picard Medical Receives NYSE American Acceptance of Compliance Plan

    Picard Medical, Inc. has been granted a compliance plan by NYSE American, allowing its stock to continue trading under ticker "PMI" while executing strategic initiatives. The company has until November 8, 2027, to meet listing standards, with updates expected. CEO Richard Fang highlights progress in advancing the Emperor Total Artificial Heart platform and strengthening financial position, aiming to create long-term shareholder value.

    07-27 11:00

  • Picard Medical announces 1-for-50 reverse stock split

    Picard Medical, Inc. ( ($PMI) ) has provided an announcement. On July 21, 2026,...

    07-22 18:28

  • Picard Medical shareholders approve governance and capital changes

    The latest update is out from Picard Medical, Inc. ( ($PMI) ). At its Annual Me...

    07-22 02:27

  • Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

    Picard Medical, Inc. announced the availability of its pre-recorded presentation ahead of its 2026 Annual Meeting of Stockholders on July 17, 2026. The presentation highlights the company's recent business progress, including an 85% year-over-year revenue increase in Q1 2026, gross margin improvement, and updates on its next-generation Emperor platform. The company also outlined proposals for stockholder consideration, including director election...

    07-13 12:00